TORONTO--(BUSINESS WIRE)--Haynes Capital Corp. will host a dinner presentation by Professor Darren Shafren of the University of Newcastle and Dr Stephen Lambros, Chief Medical Officer of Viralytics Ltd (OTC:VRACY)(ASX:VLA), on the evening of March 13, 2007.
Viralytics is an Australian Biotechnology company developing a set of natural Viruses that have cancer cell infecting properties. This therapeutic approach is referred to as Oncolytic Virotherapy. Professor Shafren discovered the viruses’ properties and published his findings in Clinical Cancer Research, in January 2004. The paper can be read in full at: